Pfizer Asks F.D.A. to Clear 2 Vaccine Doses for Young Children as a Start. Coronavirus (2019-nCoV), Vaccination and Immunization, Food and Drug Administration, Pfizer Inc, BioNTech SE, Children and Childhood, Coronavirus Omicron Variant, Clinical Trials, Centers for Disease Control and Prevention